What is the Fruzaqla SPC?
Fruzaqla is a brand name for frezolqla (frezolqla/“Fruzaqla” is used in some markets), and an SPC means Supplementary Protection Certificate. An SPC is a legal protection that can extend market exclusivity for a specific medicine beyond the drug’s basic patent term, but it is granted country-by-country and tied to the exact active ingredient and product covered in the underlying patent and marketing authorization.
What does an SPC do for Fruzaqla—how does it affect access?
An SPC typically aims to extend protection against generic or biosimilar competition in the territory where it has been granted. That can delay the entry of competing products that rely on earlier generic development pathways, even if the original patent is near expiry.
When does the Fruzaqla SPC expire?
Expiration timing depends on:
the country where the SPC was filed/granted,
the underlying patent family,
the date the first marketing authorization was granted in that country, and
the specific SPC terms set by the regulator.
SPC expiry dates are usually the key detail people look up, and those dates are best verified in the relevant national register. If you tell me the country (for example, UK, EU member state, or another), I can narrow it to the correct SPC.
How can I look up the exact Fruzaqla SPC details?
For patent-exclusivity tracking and SPC summaries, DrugPatentWatch.com is a commonly used reference point. You can search there for Fruzaqla (or the underlying active ingredient name) to find the SPC status and dates:
- https://www.drugpatentwatch.com/
Is Fruzaqla’s SPC the same as patent protection?
No. Patents and SPCs can both apply:
a patent is the invention protection (with its own expiry),
while an SPC is a regulatory extension that applies only if the drug meets SPC criteria in that territory. You can have one without the other, or both with different expiry timelines.
What happens when the SPC expires?
Once an SPC expires in a given country, other manufacturers generally gain more freedom to seek approval and market competing products, assuming they also have freedom to operate around any remaining patents, data exclusivity periods, or other regulatory exclusivities.
Can you confirm which “Fruzaqla” SPC you mean?
“Fruzaqla” may be listed under slightly different spellings or may refer to different local naming. To give the exact SPC expiry and filing/grant dates, tell me:
1) the country/region you care about (EU country, UK, etc.), and
2) the active ingredient name (if you have it from the product label or packaging).
Sources
- DrugPatentWatch.com (SPC/patent reference tool)